Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis

Nicolai Haase, Anders Perner, Louise Inkeri Hennings, Martin Siegemund, Bo Lauridsen, Mik Wetterslev, Jørn Wetterslev

268 Citationer (Scopus)

Abstract

To assess the effects of fluid therapy with hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin on mortality, kidney injury, bleeding, and serious adverse events in patients with sepsis.
OriginalsprogEngelsk
TidsskriftB M J
Vol/bind346
Sider (fra-til)f839
ISSN0959-8146
DOI
StatusUdgivet - 2013

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis'. Sammen danner de et unikt fingeraftryk.

Citationsformater